Document Detail


Efficacy of different therapeutic regimens on hepatic osteodystrophy in chronic viral liver disease.
MedLine Citation:
PMID:  21971374     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND AND AIMS: Metabolic bone disease is common in patients with chronic liver disease. Comparative studies on the efficacies of antiosteoporotic agents in hepatic osteodystrophy have not been conducted yet. The aim of this study was to evaluate the safety and efficacy of different therapeutic regimens on hepatic osteodystrophy. METHODS: Eighty-one patients (mean age 48.9±10 years; 50 cases with chronic viral hepatitis and 31 patients with cirrhosis) were enrolled in the study. Treatment groups consisted of 61 patients who had reduced T scores in at least one region, selected randomly and treated for 1 year with vitamin D 400 IU, calcitonin 200 IU, alendronate 10 mg, alendronate 70 mg, or risedronate 5 mg. An untreated group consisting of 20 patients who had no reduction in T scores was followed up during the study period. RESULTS: No significant adverse effects, including esophageal variceal hemorrhage, were detected. According to the T score at the end of the first year compared with baseline, significant improvements in bone mineral density were observed at all regions with alendronate 70 mg; improvements at the lumbar spine (LS) and distal radius regions with alendronate 10 mg; at the LS and distal radius regions with risedronate; at the LS region with calcitonin; and at the femoral neck region with vitamin D. CONCLUSION: All therapeutic regimens seemed to be safe, and oral biphosphonates were the most effective in preventing both cortical and trabecular bone loss in patients with chronic viral liver disease. Larger studies with longer follow-up are warranted in hepatic osteodystrophy of chronic viral liver diseases.
Authors:
Alper Yurci; Ali Osman Kalkan; Omer Ozbakir; Ahmet Karaman; Edip Torun; Mustafa Kula; Mevlut Baskol; Sebnem Gursoy; Mehmet Yucesoy; Fahri Bayram
Related Documents :
2009754 - Pneumatic chest wall compression. a cause of respiratory failure from massive subcutane...
7889014 - Pulmonary function and complications subsequent to autologous bone marrow transplantation.
18722134 - Subclinical idiopathic pulmonary fibrosis is also a risk factor of postoperative acute ...
3664384 - Clagett open-window thoracostomy in patients with empyema who had and had not undergone...
12717694 - The impact of the pro- and anti-inflammatory immune response on ventilation time after ...
18645114 - Surgical management and outcomes of 165 colonoscopic perforations from a single institu...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-1
Journal Detail:
Title:  European journal of gastroenterology & hepatology     Volume:  -     ISSN:  1473-5687     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9000874     Medline TA:  Eur J Gastroenterol Hepatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
aDepartment of Internal Medicine, Division of Gastroenterology bDepartment of Internal Medicine cDepartment of Nuclear Medicine dDepartment of Internal Medicine, Division of Endocrinology, School of Medicine, Erciyes University, Kayseri, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Meta-analysis: efficacy and safety of combination therapy of infliximab and immunosuppressives for ...
Next Document:  The study of relationship between neutropenia and infection during treatment with peginterferon ? an...